# Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy

> **NCT02321462** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 296 (actual)

## Conditions studied

- Bowel Cleansing

## Interventions

- **DRUG:** Eziclen
- **DRUG:** Fortrans®

## Key facts

- **NCT ID:** NCT02321462
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2019-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02321462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02321462, "Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02321462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*